Drejian S, Akhavi MS, Grzyb K, Kazaryan A, Fretland ÅA, Edwin B, Aghayan D(2026) Histopathologic growth patterns as prognostic factor for survival in patients with colorectal liver metastases Radiol Oncol(in press) DOI 10.2478/raon-2026-0002, PubMed 41686533
Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T(2026) MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer Cancers (Basel), 18(3) DOI 10.3390/cancers18030393, PubMed 41681863
Werr L, Boland J, Petersen J, Iglesias F, Höppner S, Bartenhagen C, Rosswog C, Hellmann AM, Kahlert Y, Hemstedt N, Ibruli N, Dammert MA, Decarolis B, Werner JM, Malchers F, Schramm K, Witt O, Beiske KH, Rognlien AGW, Gunnes MW, Langenberg KP, Molenaar J, Bernkopf M, Taschner-Mandl S, Hughes Det al.(2026) Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma J Clin Invest(in press) DOI 10.1172/JCI189152, PubMed 41678281
